Gsk (GSK) EBT Margin (2009 - 2026)
Gsk (GSK) posted quarterly EBT Margin of 4.21% for Q2 2026, down 1942.0% year-over-year from 0.23% in Q2 2025, and down 85.02% quarter-over-quarter from 28.1% in Q1 2026.
Gsk (GSK) EBT Margin (2009 - 2026) Analysis & Trends
Gsk's EBT Margin history runs 18 years deep, the most recent figure standing at 4.21% for Q2 2026.
- In Q2 2026, EBT Margin fell 1942.0% year-over-year to 4.21%; the TTM figure through Jun 2026 stood at 22.33% (up 453.0% YoY), while the FY2025 annual figure was 22.66%, up 1157.0% from the prior year.
- EBT Margin for Q2 2026 stood at 4.21%, down from 28.1% in the prior quarter.
- The five-year high for EBT Margin was 29.12% in Q1 2022, with the low at 0.8% in Q3 2024.
- The 5-year median for EBT Margin is 22.81% (2025), against an average of 20.9%.
- The sharpest annual moves came in 2024 and 2025: EBT Margin tumbled 2118 bps in 2024, then surged 2794 bps in 2025.
- Gsk's EBT Margin stood at 21.18% in 2022, then jumped by 30 bps to 27.56% in 2023, then plunged by 32 bps to 18.69% in 2024, then soared by 38 bps to 25.77% in 2025, then sank by 84 bps to 4.21% in 2026.
- Business Quant data shows GSK's EBT Margin at 4.21% in Q2 2026, 28.1% in Q1 2026, and 25.77% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -4.34% |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 4.21% |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 127.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.21% |
| Mar 31, 2026 | 28.10% |
| Dec 31, 2025 | 25.77% |
| Sep 30, 2025 | 28.74% |
| Jun 30, 2025 | 23.63% |
| Mar 31, 2025 | 28.05% |
| Dec 31, 2024 | 18.69% |
| Sep 30, 2024 | 0.80% |
| Jun 30, 2024 | 18.96% |
| Mar 31, 2024 | 18.40% |
| Dec 31, 2023 | 27.56% |
| Sep 30, 2023 | 21.98% |
| Jun 30, 2023 | 27.68% |
| Mar 31, 2023 | 27.43% |
| Dec 31, 2022 | 21.18% |
| Sep 30, 2022 | 12.93% |
| Jun 30, 2022 | 12.93% |
| Mar 31, 2022 | 29.12% |
| Dec 31, 2021 | 8.52% |
| Sep 30, 2021 | 17.99% |